RxDoctor Payments Data

Robert Deal

Las Vegas, NVNPI 1215118245

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $136,500 of the $174,004 with a category attached, or 78.4%. Solta Medical, A Division Of Bausch Health US, LLC accounts for 79.5% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $69,127 and has fallen 100.0% since, to $27 in 2025.

$174,004in general payments, 2019–2025

Across 165 payments — averaging $1054.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Solta Medical, A Division Of Bausch Health US, LLC$138K
  • AbbVie$28K
  • Merz North America, Inc.$7K
  • Novo Nordisk$54
  • Heron Therapeutics, Inc.$21
  • Boston Scientific$15
  • plus $27 from 2 others

What the payments were for

  • Consulting fees$136,50078%
  • Food & beverage$10,1316%
  • Education$250%
  • Gifts$27,34816%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen14$62
Ondansetron Hcl13$37

Paid to pharmacies, not to this prescriber.

Where these figures come from

Is this you, or does something look wrong? →